Photoacoustic therapy, using the photoacoustic e®ect of agents for selectively killing tumor cells, has shown promising for treating tumor. Utilization of high optical absorption probes can help to e®ectively improve the photoacoustic therapy e±ciency. Herein, we report a novel highabsorption photoacoustic probe that is composed of indocyanine green (ICG) and graphene oxide (GO), entitled GO-ICG, for photoacoustic therapy. The attached ICG with narrow absorption spectral pro¯le has strong optical absorption in the infrared region. The absorption spectrum of the GO-ICG solution reveals that the GO-ICG particles exhibited a 10-fold higher absorbance at 780 nm (its peak absorbance) as compared with GO. Importantly, ICG's°uorescence is quenched by GO via°uorescence resonance energy transfer. As a result, GO-ICG can high-e±ciently convert the absorbed light energy to acoustic wave under pulsed laser irradiation. We further demonstrate that GO-ICG can produce stronger photoacoustic wave than the GO and ICG alone. Moreover, we conjugate this contrast agent with integrin v 3 mono-clonal antibody to molecularly target the U87-MG human glioblastoma cells for selective tumor cell killing. Finally, our results testify that the photoacoustic therapy e±ciency of GO-ICG is higher than the existing photoacoustic therapy agent. Our work demonstrates that GO-ICG is a high-e±ciency photoacoustic therapy agent. This novel photoacoustic probe is likely to be an available candidate for tumor therapy.